T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
41 hedge funds and large institutions have $151M invested in T2 Biosystems, Inc in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 10 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
21% more call options, than puts
Call options by funds: $265K | Put options by funds: $219K
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2% less capital invested
Capital invested by funds: $155M → $151M (-$3.78M)
15% less funds holding
Funds holding: 48 → 41 (-7)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$3.02M |
| 2 |
SM
Senvest Management
New York
|
+$1.64M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$526K |
| 4 |
TM
Tiger Management
New York
|
+$427K |
| 5 |
PVI
Pura Vida Investments
New York
|
+$394K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$3.25M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.77M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.05M |
| 4 |
SIM
Spark Investment Management
New York
|
-$791K |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$624K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PFG
51
Piershale Financial Group
Barrington,
Illinois
| $1K | – | – | – |
|
|
WTB
52
Washington Trust Bank
Spokane,
Washington
| $1K | – | – | – |
|
|
TCIM
53
TIAA CREF Investment Management
New York
| $284 | – | – | – |
|
|
GGHC
54
Gilder Gagnon Howe & Co
New York
| – | -$3.25M | -82 | Closed |
|
|
SIM
55
Spark Investment Management
New York
| – | -$791K | -20 | Closed |
|
|
TC
56
TFS Capital
West Chester,
Pennsylvania
| – | -$154K | -4 | Closed |
|
|
VKH
57
Virtu KCG Holdings
New York
| – | -$100K | -3 | Closed |
|
|
CS
58
Credit Suisse
Zurich,
Switzerland
| – | -$88K | -2 | Closed |
|
59
D.E. Shaw & Co
New York
| – | -$93K | -2 | Closed |
|
60
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$63K | -2 | Closed |
|
|
PPA
61
Parametric Portfolio Associates
Seattle,
Washington
| – | -$89K | -2 | Closed |
|
62
JP Morgan Chase
New York
| – | -$20K | -1 | Closed |
|
|
TRCT
63
Tower Research Capital (TRC)
New York
| – | -$30K | -1 | Closed |
|
|
CSS
64
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$8K | – | – |
|
|
SFPM
65
Sensible Financial Planning & Management
Waltham,
Massachusetts
| – | -$5K | – | – |
|
TTOO Hedge Fund Activity: Q3 2016 in Review
41 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2016, worth a combined $151M — down 2.4% from $155M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of TTOO and 4 opened new positions — a net loss of 6 holders — while 5 trimmed existing stakes and 10 added.
The largest buyer was Lagoda Investment Management, adding an estimated $3.02M. The largest seller was Gilder Gagnon Howe & Co, exiting entirely with an estimated $3.25M sold.
- 41 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2016, down from 48 in Q2 2016.
- Funds reported $151M of T2 Biosystems, Inc stock for Q3 2016, down 2.4% quarter-over-quarter.
- 4 funds opened new T2 Biosystems, Inc positions in Q3 2016 and 10 closed out, a net change of -6 holders.
- The largest T2 Biosystems, Inc buyer in Q3 2016 was Lagoda Investment Management, an estimated $3.02M added.
- The largest T2 Biosystems, Inc seller in Q3 2016 was Gilder Gagnon Howe & Co, an estimated $3.25M sold.
Based on aggregated 13F filings for Q3 2016.